WallStSmart
FULC

Fulcrum Therapeutics Inc

NASDAQ: FULC · HEALTHCARE · BIOTECHNOLOGY

$3.75
+1.35% today

Updated 2026-10-28

Market cap
$282.61M
P/E ratio
—
P/S ratio
2.66x
EPS (TTM)
$-1.21
Dividend yield
—
52W range
$3 – $16
Volume
1.4M

Fulcrum Therapeutics Inc (FULC) Insider transactions

Net insider activity
Net buying (4,786,208 shares)
Buy transactions
82
Sell transactions
18

All transactions

DateInsiderTitleTypeSharesPriceValue
2026-07-17TANG, KEVIN10% OwnerBuy50,945$3.52$179326.40
2026-07-16TANG, KEVIN10% OwnerBuy116,671$3.56$415348.76
2026-07-15TANG, KEVIN10% OwnerBuy107,377$3.56$382262.12
2026-07-14TANG, KEVIN10% OwnerBuy75,952$3.58$271908.16
2026-07-14TANG, KEVIN10% OwnerBuy53,651$3.56$190997.56
2026-07-13TANG, KEVIN10% OwnerBuy12,966$3.54$45899.64
2026-06-30KING, RACHEL K.DirectorBuy32,000——
2026-06-30HILL, COLINDirectorBuy32,000——
2026-06-30HAVILAND, KATEDirectorBuy32,000——
2026-06-30GOULD, ROBERT JDirectorBuy32,000——
2026-06-30GERAGHTY, JAMES ADirectorBuy32,000——
2026-06-30EZEKOWITZ, ALANDirectorBuy32,000——
2026-06-30DORTON, KATINADirectorBuy32,000——
2026-06-30BANKS, SONJADirectorBuy32,000——
2026-06-26EZEKOWITZ, ALANDirectorSale18,000$3.65$65613.60
2026-04-23LEHRER-GRAIWER, JOSHUADirectorBuy64,000——
2026-02-02TOURANGEAU, GREGPrincipal Accounting OfficerBuy57,000——
2026-02-02SAPIR, ALEXDirector, See RemarksBuy650,000——
2026-02-02OLTMANS, CURTIS GALEChief Legal OfficerBuy170,000——
2026-02-02MUSSO, ALAN AChief Financial OfficerBuy170,000——
2026-02-02GOULD, ROBERT JDirectorSale15,000$10.72$160857.00
2026-01-02GOULD, ROBERT JDirectorSale15,000$10.87$163089.00
2025-12-15OLTMANS, CURTIS GALEChief Legal OfficerSale3,452$12.92$44599.84
2025-12-08RA, CAPITAL MANAGEMENT, L.P.10% OwnerSale2,706,397$14.28$38.65M
2025-12-08RA, CAPITAL MANAGEMENT, L.P.10% OwnerSale1,377,020$13.33$18.36M
2025-12-08RA, CAPITAL MANAGEMENT, L.P.10% OwnerSale91,722$14.98$1.37M
2025-11-19GOULD, ROBERT JDirectorSale15,000$11.03$165495.00
2025-06-26KING, RACHEL K.DirectorBuy36,000——
2025-06-26HILL, COLINDirectorBuy36,000——
2025-06-26HAVILAND, KATEDirectorBuy36,000——
2025-06-26GOULD, ROBERT JDirectorBuy36,000——
2025-06-26GERAGHTY, JAMES ADirectorBuy36,000——
2025-06-26EZEKOWITZ, ALANDirectorBuy36,000——
2025-06-26DORTON, KATINADirectorBuy36,000——
2025-06-26BANKS, SONJADirectorBuy36,000——
2025-05-08TOURANGEAU, GREGPrincipal Accounting OfficerSale498$5.06$2519.88
2025-01-24TOURANGEAU, GREGPrincipal Accounting OfficerBuy76,120——
2025-01-24SAPIR, ALEXDirector, See RemarksBuy582,000——
2025-01-24OLTMANS, CURTIS GALEChief Legal OfficerBuy225,000——
2025-01-24MUSSO, ALAN AChief Financial OfficerBuy285,000——
2024-11-12KING, RACHEL K.DirectorBuy60,000——
2024-08-21RA, CAPITAL MANAGEMENT, L.P.10% OwnerBuy8,500,000——
2024-08-21RA, CAPITAL MANAGEMENT, L.P.10% OwnerSale8,500,000——
2024-07-03SAPIR, ALEXDirector, See RemarksSale150,000——
2024-07-03SAPIR, ALEXDirector, See RemarksBuy150,000$3.27$490500.00
2024-06-17HILL, COLINDirectorBuy60,000——
2024-06-17HAVILAND, KATEDirectorBuy30,000——
2024-06-17GOULD, ROBERT JDirectorBuy30,000——
2024-06-17GERAGHTY, JAMES ADirectorBuy30,000——
2024-06-17EZEKOWITZ, ALANDirectorBuy30,000——
2024-06-17DORTON, KATINADirectorBuy30,000——
2024-06-17COLLINS, JAMES J.DirectorBuy30,000——
2024-06-17BANKS, SONJADirectorBuy30,000——
2024-05-07TOURANGEAU, GREGPrincipal Accounting OfficerSale236$7.76$1831.36
2024-03-18HORN, PATRICK TAYLORChief Medical OfficerBuy400,000——
2024-03-08TOURANGEAU, GREGVice President, FinanceSale4,884$11.72$57218.50
2024-03-04SAPIR, ALEXDirector, See RemarksBuy43,360$11.35$492027.60
2024-01-26TOURANGEAU, GREGVice President, FinanceBuy83,820——
2024-01-26TOURANGEAU, GREGVice President, FinanceBuy10,000——
2024-01-26OLTMANS, CURTIS GALEChief Legal OfficerBuy150,000——
2024-01-26MUSSO, ALAN AChief Financial OfficerBuy100,000——
2024-01-17MUSSO, ALAN AChief Financial OfficerBuy61,822——
2023-08-07MUSSO, ALAN AChief Financial OfficerBuy432,800——
2023-06-27HAVILAND, KATEDirectorBuy30,000——
2023-06-27GOULD, ROBERT JDirector, Interim President & CEOBuy30,000——
2023-06-27GERAGHTY, JAMES ADirectorBuy30,000——
2023-06-27EZEKOWITZ, ALANDirectorBuy30,000——
2023-06-27DORTON, KATINADirectorBuy30,000——
2023-06-27COLLINS, JAMES J.DirectorBuy30,000——
2023-06-27BANKS, SONJADirectorBuy30,000——
2023-05-10TOURANGEAU, GREGPrincipal Accounting OfficerSale210$3.31$695.10
2023-04-26OLTMANS, CURTIS GALEChief Legal OfficerBuy127,500——
2023-04-26HAYES, MELVIN H. IIIChief Operating OfficerBuy115,000——
2023-02-09TOURANGEAU, GREGControllerBuy16,100——
2023-02-09RAJAVELU, ESTHERChief Financial OfficerBuy160,000——
2023-02-09OLTMANS, CURTIS GALEChief Legal OfficerBuy150,000——
2023-02-09HAYES, MELVIN H. IIIChief Operating OfficerBuy135,000——
2023-01-20RA, CAPITAL MANAGEMENT, L.P.10% OwnerBuy1,923,076$13.00$25.00M
2023-01-13GOULD, ROBERT JDirector, Interim President & CEOSale6,766$15.00$101490.00
2023-01-04RA, CAPITAL MANAGEMENT, L.P.10% OwnerBuy122,334$7.03$859714.42
2023-01-04RA, CAPITAL MANAGEMENT, L.P.10% OwnerBuy58,369$7.80$455091.42
2022-12-27RA, CAPITAL MANAGEMENT, L.P.10% OwnerBuy4,089$5.99$24509.87
2022-12-19RA, CAPITAL MANAGEMENT, L.P.10% OwnerBuy98,787$5.90$582813.66
2022-12-16RA, CAPITAL MANAGEMENT, L.P.10% OwnerBuy1,341,420$5.42$7.27M
2022-12-15RA, CAPITAL MANAGEMENT, L.P.10% OwnerBuy237,029$5.50$1.30M
2022-12-14RA, CAPITAL MANAGEMENT, L.P.10% OwnerBuy824,600$5.46$4.50M
2022-12-13THIRD, ROCK VENTURES III, L.P.10% OwnerSale2,000,000——
2022-11-07ARROYO, SANTIAGOChief Medical OfficerBuy400,000——
2022-08-09OLTMANS, CURTIS GALEChief Legal OfficerBuy50,000——
2022-08-09HAYES, MELVIN H. IIIChief Operating OfficerBuy137,000——
2022-07-15TOURANGEAU, GREGControllerBuy16,540——
2022-06-28EZEKOWITZ, ALANDirectorSale500——
2022-06-27HAVILAND, KATEDirectorBuy19,000——
2022-06-27GOULD, ROBERT JDirectorBuy19,000——
2022-06-27GERAGHTY, JAMES ADirectorBuy19,000——
2022-06-27EZEKOWITZ, ALANDirectorBuy19,000——
2022-06-27DORTON, KATINADirectorBuy19,000——
2022-06-27COLLINS, JAMES J.DirectorBuy19,000——
2022-06-27BANKS, SONJADirectorBuy19,000——
2022-06-07GOULD, ROBERT JDirectorSale71,435——

Frequently asked questions

Are FULC insiders buying or selling?

Over the transactions on record, FULC insiders have been net buyers, with about $59.14M in stock sold across 18 sales, against 16 open-market purchases.

Does insider selling at FULC mean the stock will fall?

Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.

Which FULC insiders are selling the most?

Recent selling is concentrated in a few names. RA, CAPITAL MANAGEMENT, L.P. accounts for the largest share on record, with about $58.38M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.